Back to search

Article

Rare Germline Variants in Immune and Drug Target Genes Among Cancer Exceptional Responders

2026-05-19

Abstract excerpt

<h4>Background</h4> Cancer treatment response is highly variable, even among patients with the same tumor type and treatment. Exceptional responders (ERs), who are individuals who experience unusually favorable outcomes, provide critical insights into the biological factors driving treatment success. While prior studies have highlighted the role of somatic changes, the contribution of germline rare variants remai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86a11664-507b-5330-99e7-7826775f6ec3
DOI
10.64898/2026.05.14.26352838
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rare Germline Variants in Immune and Drug Target Genes Among Cancer Exceptional RespondersDOI 10.64898/2026.05.14.26352838
Molecular Profiling of Exceptional Responders to Cancer Therapy.Semantic proximity
What have we learned from exceptional tumour responses?: Review and perspectives.Semantic proximity
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Semantic proximity
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.Semantic proximity
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersSemantic proximity
Genomic landscape of extraordinary responses in metastatic breast cancer.Semantic proximity
Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer.Semantic proximity
Polygenic risk scores for autoimmune related diseases are significantly different and skewed in cancer exceptional respondersSemantic proximity
Transforming Biomarker Development with Exceptional Responders.Semantic proximity
Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristicsSemantic proximity
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivorsSemantic proximity
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits.Semantic proximity
Select a neighboring publication to make it the new centre.